从「燃尽」到「正在燃尽」:从动态视角捕捉晚期代谢功能障碍相关脂肪性肝病患者的肝脏脂肪丢失
该研究基于16个中心的MASLD队列,纳入3273例有基线组织学及5455例有连续VCTE测量的患者,提出「正在燃尽」概念描述肝脂肪随纤维化进展持续丢失的过程。435例「燃尽」MASLD患者全因死亡、肝脏相关事件和肝失代偿风险均高于晚期纤维化伴明显脂肪变者;176例「正在燃尽」患者上述不良结局累积发生率更高。
要点
- 「燃尽」MASLD定义为脂肪变分级≤S1且纤维化分期≥F3,其全因死亡风险比为2.14。
- 「燃尽」患者肝脏相关事件风险比1.77,肝失代偿风险比1.83。
- 「正在燃尽」患者全因死亡率7.28/1000人年,肝脏相关事件26.47/1000人年。
核心结论
- 晚期MASLD中可观察到伴随纤维化进展的持续肝脏脂肪丢失即「正在燃尽」,与全因死亡、肝脏相关事件和肝失代偿的高发生率相关。
研究设计与样本
- 研究纳入来自16个中心的MASLD队列,包括3273例有基线组织学评估的个体和5455例随访期间有连续振动控制瞬时弹性成像测量的个体。
主要发现
- 3273例组织学评估患者中435例为「燃尽」MASLD,其全因死亡风险高于晚期纤维化伴明显脂肪变者(HR 2.14,95%CI 1.14-4.02)。
- 「燃尽」MASLD患者肝脏相关事件风险(HR 1.77,95%CI 1.12-2.78)和肝失代偿风险(HR 1.83,95%CI 1.11-3.01)均高于晚期纤维化伴明显脂肪变者。
- 5455例VCTE轨迹分析患者中176例为「正在燃尽」MASLD,其全因死亡率、肝脏相关事件发生率和肝失代偿发生率分别为7.28、26.47和21.92/1000人年。
- 「正在燃尽」组不良结局累积发生率高于持续高CAP且中/低LSM值的患者(P < .0001)。
关键数值与推荐
- 「燃尽」MASLD定义为脂肪变分级≤S1且纤维化分期≥F3。
- 「正在燃尽」通过轨迹分析识别,表现为CAP值持续下降和LSM值持续升高的趋势。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: The absence of hepatic fat in advanced fibrosis has been documented in metabolic dysfunction-associated steatotic liver disease ("burnt-out" MASLD). However, whether hepatic fat loss occurs continuously with fibrosis progression is controversial. We proposed a "burning-out" concept to describe this process and analyze the long-term outcomes of "burnt-out" and "burning-out" MASLD. METHODS: We included a MASLD cohort from 16 centers, including 3273 individuals with baseline histology and 5455 with serial vibration-controlled transient elastography measurements during the follow-up. "Burnt-out" MASLD was defined by steatosis grade ≤S1 and fibrosis stage ≥F3. Trajectory analysis identified "burning-out" patients with continuous trends of decreasing controlled attenuation parameter and increasing liver stiffness measurement values. RESULTS: Of 3273 patients with histologic evaluation included, 435 had "burnt-out" MASLD. Compared with those with pronounced steatosis in advanced fibrosis, patients with "burnt-out" had higher risks of all-cause mortality (hazard ratio [HR], 2.14; 95% confidence interval [CI], 1.14-4.02), liver-related events (LREs; HR, 1.77; 95% CI, 1.12-2.78), and hepatic decompensation (HR, 1.83; 95% CI, 1.11-3.01). Of 5455 patients with vibration-controlled transient elastography included for trajectory analysis, 176 were identified as "burning-out" MASLD. The incidence rates of all-cause mortality, LREs, and decompensation were 7.28, 26.47, and 21.92 per 1000 person-years in "burning-out" patients, respectively. The "burning-out" group had higher cumulative incidences of adverse outcomes than patients with consistently high controlled attenuation parameter and moderate/low liver stiffness measurement values (P < .0001). CONCLUSIONS: Continuous hepatic fat loss accompanied by fibrosis progression, referred to as "burning-out," was observed in advanced MASLD and associated with high rates of all-cause mortality, LREs, and hepatic decompensation.
引用
- Liu WY, Huang S, Ji H, et al. From "Burnt-Out" to "Burning-Out": Capturing Liver Fat Loss in Patients With Advanced Metabolic Dysfunction-Associated Steatotic Liver Disease From a Dynamic Perspective. Gastroenterology. 2025. PMID: 40113099. doi:10.1053/j.gastro.2025.02.034
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。